Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis

British Journal of Rheumatology

Volumn 37, Issue 8, 1998, Pages 901-907

  Muller Kobold, A C ^a   Kallenberg, C G M ^b   Cohen Tervaert, J W ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

ANCA; Disease activity; Flow cytometry; Pr3 membrane expression; Wegener's granulomatosis

Indexed keywords

LEUKOCYTE ELASTASE; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; LEUKOCYTE MEMBRANE; MALE; MONOCYTE; PRIORITY JOURNAL; WEGENER GRANULOMATOSIS;

EID: 0031826477     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.8.901     Document Type: Article

References (28)

1. Kallenberg CGM, Brouwer E, Weening JJ, Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994;46:1-15.
2. Cohen Tervaert JW, Mulder L, Stegeman C et al. Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 1993;52:115-20.
3. Cohen Tervaert JW, van der Woude FJ, Fauci AS et al. Association between active Wegener's granulomatosis and antineutrophil cytoplasmic antibodies. Arch Intern Med 1989;149:2461-5.
4. Cohen Tervaert JW, Huitema MG, Hene RJ et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990;336:709-11.
5. Kallenberg CGM, Brouwer E, Mulder AH, Stegeman CA, Weening JJ, Tervaert JW. ANCA - pathophysiology revisited. Clin Exp Immunol 1995;100:1-3.
6. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-9.
7. Charles LA, Caldas ML, Falk RJ, Terrell RS, Jennette JC. Antibodies against granule proteins activate neutrophils in vitro. J Leukocyte Biol 1991;50:539-46.
8. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 1994;95:244-50.
9. Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, Kimberly RP. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 1994;153:1271-80.
10. Mulder AH, Heeringa P, Brouwer E, Limburg PC, Kallenberg CGM. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process. Clin Exp Immunol 1994;98:270-8.
11. Cohen Tervaert JW. The value of serial ANCA testing during follow-up studies in patients with ANCA associated vasculitides. A review. J Nephrol 1996;9:232-240.
12. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
13. Leavitt RY, Fauci AS, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
14. Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CGM. Trimethoprim-sulfamethoxazole (cotrimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996;335:16-20.
15. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994;87:671-8.
16. Cohen Tervaert JW, Goldschmeding R, Elema JD et al. Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 1990;37: 799-806.
17. Kuijpers TW, Tool AT, van der School CE et al. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 1991;78:1105-11.
18. Hamblin A, Taylor M, Bernhagen J et al. A method of preparing blood leucocytes for flow cytometry which prevents upregulation of leucocyte integrins. J Immunol Methods 1992;146:219-28.
19. Sladek TL, Jacobberger JW. Flow cytometric titration of retroviral expression vectors: comparison of methods for analysis of immunofluorescence histograms derived from cells expressing low antigen levels. Cytometry 1993;14:23-31.
20. Halbwachs-Mecarelli L, Bessou G, Lesavre P, Lopez S, Witko Sarsat V. Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. FEBS Lett 1995;374:29-33.
21. Pinching AJ, Rees AJ, Pussell BA, Lockwood CM, Mitchison RS, Peters DK. Relapses in Wegener's granulomatosis: the role of infection. Br Med J 1980; 281:836-8.
22. Gilligan HM, Bredy B, Brady HR et al. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 1996;184:2231-41.
23. Macey MG, Jiang XP, Veys P, McCarthy D, Newland AC. Expression of functional antigens on neutrophils. Effects of preparation. J Immunol Methods 1992;149: 37-42.
24. Ralston DR, Marsh CB, Lowe MP, Wewers MD. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase 3, alpha 1-antitrypsin, and Fcgamma receptors. J Clin Invest 1997;100:1416-24.
25. Franssen CF, Gans RO, Arends B et al. Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease. Kidney Int 1995;47:193-9.
26. Cohen Tervaert JW, Elema JD, Kallenberg CGM. Clinical and histopathological association of 29kD-ANCA and MPO-ANCA. APMIS 1990;19(suppl.):35.
27. Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ. Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 1995;86:3189-95.
28. Johnson PA, Alexander HD, McMillan SA, Maxwell AP. Up-regulation of the granulocyte adhesion molecule Mac-1 by autoantibodies in autoimmune vasculitis. Clin Exp Immunol 1997;107:513-9.